The Blood-Cerebrospinal Fluid Barrier Dysfunction in Brain Disorders and Stroke: Why, How, What For?
- PMID: 39278883
- DOI: 10.1007/s12017-024-08806-0
The Blood-Cerebrospinal Fluid Barrier Dysfunction in Brain Disorders and Stroke: Why, How, What For?
Abstract
Ischemic stroke (IS) results in the interruption of blood flow to the brain, which can cause significant damage. The pathophysiological mechanisms of IS include ionic imbalances, oxidative stress, neuroinflammation, and impairment of brain barriers. Brain barriers, such as the blood-brain barrier (BBB) and the blood-cerebrospinal fluid (CSF) barrier (B-CSF), protect the brain from harmful substances by regulating the neurochemical environment. Although the BBB is widely recognized for its crucial role in protecting the brain and its involvement in conditions such as stroke, the B-CSF requires further study. The B-CSF plays a fundamental role in regulating the CSF environment and maintaining the homeostasis of the central nervous system (CNS). However, the impact of B-CSF impairment during pathological events such as IS is not yet fully understood. In conditions like IS and other neurological disorders, the B-CSF can become compromised, allowing the entry of inflammatory substances and increasing neuronal damage. Understanding and preserving the integrity of the B-CSF are crucial for mitigating damage and facilitating recovery after ischemic stroke, highlighting its fundamental role in regulating the CNS during adverse neurological conditions.
Keywords: Blood-cerebrospinal fluid barrier; Brain; Central nervous system; Cerebrospinal fluid; Ischemic stroke.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Procarboxypeptidase U (proCPU, TAFI, proCPB2) in cerebrospinal fluid during ischemic stroke is associated with stroke progression, outcome and blood-brain barrier dysfunction.J Thromb Haemost. 2018 Feb;16(2):342-348. doi: 10.1111/jth.13914. Epub 2017 Dec 26. J Thromb Haemost. 2018. PMID: 29194929
-
Neuroinflammation, Stroke, Blood-Brain Barrier Dysfunction, and Imaging Modalities.Stroke. 2022 May;53(5):1473-1486. doi: 10.1161/STROKEAHA.122.036946. Epub 2022 Apr 7. Stroke. 2022. PMID: 35387495 Free PMC article. Review.
-
The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.Semin Immunopathol. 2009 Nov;31(4):497-511. doi: 10.1007/s00281-009-0177-0. Epub 2009 Sep 25. Semin Immunopathol. 2009. PMID: 19779720 Review.
-
[Cerebrospinal fluid proteins in the diagnosis of disorders of the blood-cerebrospinal fluid barrier in central nervous system diseases].Bratisl Lek Listy. 1998 Jul;99(7):347-50. Bratisl Lek Listy. 1998. PMID: 9748723 Slovak.
-
Targeted BRD4 protein degradation by dBET1 ameliorates acute ischemic brain injury and improves functional outcomes associated with reduced neuroinflammation and oxidative stress and preservation of blood-brain barrier integrity.J Neuroinflammation. 2022 Jun 27;19(1):168. doi: 10.1186/s12974-022-02533-8. J Neuroinflammation. 2022. PMID: 35761277 Free PMC article.
Cited by
-
Astrocytes and Tinnitus.Brain Sci. 2024 Nov 29;14(12):1213. doi: 10.3390/brainsci14121213. Brain Sci. 2024. PMID: 39766412 Free PMC article. Review.
-
Impaired Flow: Glymphatic Dysfunction in Ischemic Stroke and the Influence of Sex.J Mol Neurosci. 2025 Jul 4;75(3):85. doi: 10.1007/s12031-025-02377-w. J Mol Neurosci. 2025. PMID: 40615764 Review.
References
-
- Anastassiadis, C., Vasilevskaya, A., Gumus, M., Santos, A., & Tartaglia, M. C. (2021). Fluid biomarkers of white matter hyperintensities in cerebrovascular disease and neurodegeneration: A systematic review protocol. JBI Evidence Synthesis, 19(9), 2464–2473. https://doi.org/10.11124/JBIES-20-00210 - DOI - PubMed
-
- Balusu, S., Brkic, M., Libert, C., & Vandenbroucke, R. (2016). The choroid plexus-cerebrospinal fluid interface in Alzheimer′s disease: More than just a barrier. Neural Regeneration Research, 11(4), 534. https://doi.org/10.4103/1673-5374.180372 - DOI - PubMed - PMC
-
- Batra, A., Latour, L. L., Ruetzler, C. A., Hallenbeck, J. M., Spatz, M., Warach, S., & Henning, E. C. (2010). Increased plasma and tissue MMP levels are associated with BCSFB and BBB disruption evident on post-contrast FLAIR after experimental stroke. Journal of Cerebral Blood Flow & Metabolism, 30(6), 1188–1199. https://doi.org/10.1038/jcbfm.2010.1 - DOI
-
- Beridze, M., Sanikidze, T., Shakarishvilil, R., Intskirveli, N., & Bornstein, N. M. (2011). Selected acute phase CSF factors in ischemic stroke: Findings and prognostic value. BMC Neurology, 11(1), 41. https://doi.org/10.1186/1471-2377-11-41 - DOI - PubMed - PMC
-
- Boesl, F., Goereci, Y., Gerhard, A., Bremer, B., Raeder, V., Schweitzer, F., Hoppmann, U., Behrens, J., Bellmann-Strobl, J., Paul, F., & Wildemann, B. (2024). Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome. Journal of Neurology, 271(1), 59–70. https://doi.org/10.1007/s00415-023-12092-4 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical